Impact of Hypoxia on Resting and Exertional Right Ventricular Performance
1 other identifier
observational
10
1 country
1
Brief Summary
The purpose of this study is to better understand how hypoxia (low oxygen) affects resting and exertional right ventricular function in healthy individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2022
CompletedFirst Posted
Study publicly available on registry
March 9, 2022
CompletedStudy Start
First participant enrolled
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedMay 9, 2023
May 1, 2023
5 months
February 8, 2022
May 5, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Right ventricular contractility measured by conductance catheter
End-systolic elastance (Ees) in mmHg/mL
Up to 1 hour
Right ventricular lusitropy (diastolic function) measured by conductance catheter
Minimum dp/dt in mmHg/sec
Up to 1 hour
Secondary Outcomes (7)
Right ventricular stroke work measured by conductance catheter
Up to 1 hour
Mean pulmonary artery pressure measured by right heart catheterization
Up to 1 hour
Cardiac output derived from right heart catheterization
Up to 1 hour
Workload
Up to 1 hour
Maximal oxygen uptake
Up to 1 hour
- +2 more secondary outcomes
Study Arms (1)
Healthy individuals
10 healthy individuals will be recruited.
Interventions
Individuals will be exposed to varying levels of hypoxia according to the protocol detailed above.
Eligibility Criteria
10 healthy men and women
You may qualify if:
- Age 18 - 60
- For women, premenopausal status
You may not qualify if:
- Active cardiovascular or pulmonary disease (e.g. hypertension, coronary artery disease, cardiomyopathy, arrhythmia, valvular abnormalities, diabetes, peripheral vascular disease, tobacco use, chronic obstructive pulmonary disease, asthma, interstitial lung disease, restrictive lung disease, or pulmonary hypertension)
- Use of cardiac- or pulmonary-related medications
- Prior history of high altitude pulmonary edema or high altitude cerebral edema
- Body mass index \< 18.5 or \> 30
- Anemia
- Iron deficiency
- Iron supplementation (oral or intravenous) in the preceding 60 days
- Systemic anticoagulation or aspirin use that cannot be temporarily held for the study
- Pregnancy
- Non-cardiopulmonary disorders that adversely influence exercise ability (e.g. arthritis or peripheral vascular disease)
- Dedicated athletic training (defined here as spending \>9 hours per week in vigorous physical activity \[≥6 mets\])
- Regular high-altitude exercise (defined here as engaging in vigorous physical activity \[≥1 hour at ≥6 mets\] at ≥8,000 ft for \>2 days per week over the preceding 4 weeks)
- Residence at ≥8,000 ft for 3 or more consecutive nights in the preceding 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Related Publications (5)
Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, Ratcliffe PJ, Robbins PA. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol. 2008 Dec 15;586(24):5999-6005. doi: 10.1113/jphysiol.2008.160960. Epub 2008 Oct 27.
PMID: 18955380BACKGROUNDSmith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, Leon-Velarde F, Robbins PA. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA. 2009 Oct 7;302(13):1444-50. doi: 10.1001/jama.2009.1404.
PMID: 19809026BACKGROUNDCornwell WK, Tran T, Cerbin L, Coe G, Muralidhar A, Hunter K, Altman N, Ambardekar AV, Tompkins C, Zipse M, Schulte M, O'Gean K, Ostertag M, Hoffman J, Pal JD, Lawley JS, Levine BD, Wolfel E, Kohrt WM, Buttrick P. New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis. J Physiol. 2020 Jul;598(13):2575-2587. doi: 10.1113/JP279759. Epub 2020 May 18.
PMID: 32347547BACKGROUNDCornwell WK 3rd, Baggish AL, Bhatta YKD, Brosnan MJ, Dehnert C, Guseh JS, Hammer D, Levine BD, Parati G, Wolfel EE; American Heart Association Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; and Council on Arteriosclerosis, Thrombosis and Vascular Biology. Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2021 Oct 5;10(19):e023225. doi: 10.1161/JAHA.121.023225. Epub 2021 Sep 9.
PMID: 34496612BACKGROUNDForbes LM, Bull TM, Lahm T, Lawley JS, Hunter K, Levine BD, Lovering A, Roach RC, Subudhi AW, Cornwell WK 3rd. Right Ventricular Response to Acute Hypoxia among Healthy Humans. Am J Respir Crit Care Med. 2023 Aug 1;208(3):333-336. doi: 10.1164/rccm.202303-0599LE. No abstract available.
PMID: 37311248DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2022
First Posted
March 9, 2022
Study Start
April 15, 2022
Primary Completion
August 30, 2022
Study Completion
December 15, 2022
Last Updated
May 9, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share